Mynd Healthcare

Library / regulatory-reference

Tunisia: Pharmacy and Medicines Directorate (DPM) and the National Medicines Agency

Audience: administrators-policy, researchers-scientists ยท Review state: published

The national authority

Tunisia's medicines regulation has historically rested with the Pharmacy and Medicines Directorate, known by its French initials DPM, within the Ministry of Health, and the country has been creating a dedicated national agency for medicines and health products to take over regulatory functions.

Tunisia has a substantial domestic pharmaceutical industry supplying much of the local market, so its regulator oversees both imports and local production.

How products enter the market

Medicines require marketing authorization after evaluation of quality, safety and efficacy, and establishments are licensed and inspected, with a national formulary guiding which products are used in the health system.

Post-market work includes safety alerts, quality surveillance and action against falsified products, with public alerts issued to professionals and the public.

Regional and international role

Tunisia participates in North African and francophone regulatory cooperation, and its domestic industry's export orientation gives its oversight regional significance.

The move toward a standalone national agency follows the wider pattern of separating medicines regulation from ministry administration.

Using this profile

The directorate publishes regulations, the national formulary and safety alerts in French and Arabic through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.

For cross-country comparison: Tunisia illustrates a producer-market regulator in transition from a ministry directorate to a dedicated national agency.

Limitations

Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.